Filtered By:
Condition: Chronic Obstructive Pulmonary

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 1666 results found since Jan 2013.

Study Questions Use of Branded Inhalers for COPD Study Questions Use of Branded Inhalers for COPD
Researchers said their analysis found that a generic product approved in 2019 was equally effective as the more expensive original.Medscape Medical News
Source: Medscape Allergy Headlines - August 8, 2023 Category: Allergy & Immunology Tags: Internal Medicine News Source Type: news

Pre-COPD Current and Former Smokers Not in the Clear for Airway Disease
(MedPage Today) -- Whether they had respiratory symptoms or not, former and current smokers who didn't meet criteria for chronic obstructive pulmonary disease (COPD) had similar declines in lung function and progression to COPD in subsequent years...
Source: MedPage Today Allergy - August 2, 2023 Category: Allergy & Immunology Source Type: news

News beyond our pages
Because type 2 inflammation is present in a significant proportion of patients with chronic obstructive pulmonary disease (COPD) and increases exacerbation risk, Bhatt et al (N Engl J Med 2023; https://doi.org/10.1056/NEJMoa2303951) performed a randomized, placebo-controlled phase 3 trial to investigate the efficacy of dupilumab, an mAb that inhibits the signaling of both IL-4 and IL-13 in symptomatic patients with COPD with a blood eosinophil count of at least 300 per μL. As compared to placebo, dupilumab decreased the annualized rate of exacerbations and improved lung function, quality of life, and symptom control.
Source: Journal of Allergy and Clinical Immunology - August 1, 2023 Category: Allergy & Immunology Tags: News beyond our pages Source Type: research

Clinical Characteristics and Economic Burden of Asthma in China: A Multicenter Retrospective Study
Iran J Allergy Asthma Immunol. 2023 Jun 16;22(3):290-298. doi: 10.18502/ijaai.v22i3.13057.ABSTRACTAsthma is a common chronic airway inflammation that produces a healthcare burden on the economy. We aim to obtain a better understanding of the clinical status and disease burden of patients with asthma in China. A retrospective study was carried out based on the computerized medical records in the Jinan Health Medical Big Data Platform between 2011 and 2019 (available data from 38 hospitals). The asthma severity of each patient was assessed retrospectively and categorized as mild, moderate, or severe according to Global Initi...
Source: Iranian Journal of Allergy, Asthma and Immunology - July 31, 2023 Category: Allergy & Immunology Authors: Bin Shang Xiangguo Li Yu Xu Wenxin Ren Junren Wang Chunyan Xing Shujuan Jiang Jian Sun Source Type: research